Lars Klareskog
Associate Director
Medical Science
Oxypharma
Sweden
Biography
Professor in Rheumatology, Rheumatology Unit, Department of Medicine, Karolinska Institutet at Karolinska University Hospital. Involvement with OxyPharma: Conducts research into the mechanism of action of OxyPharma's RA compounds and Principal Investigator for the ongoing phase II study of Rabeximod. .
Research Interest
His research interests lie in Healthcare and Medical Sciences. He is the Editor-in-Chief Member of many peer reviewed journals and his area of expertise credits him with many publications in national and international journals. He is committed to highest standards of excellence and it proves through his authorship of many books.
